Obstructive hypertrophic cardiomyopathy results from asymmetric septal hypertrophy, which
eventually obstructs the outflow of the left ventricle. Obstructive hypertrophic cardiomyopathy …

Hypertrophic cardiomyopathy (HCM) is a hereditary cardiac condition characterized by
unexplained left ventricular hypertrophy without a hemodynamic cause. This condition is …

Background Hypertrophic cardiomyopathy (HCM) is a hereditary disease manifested by a
thickened ventricular wall. Cysteine and glycine‐rich protein 3 (CSRP3), the gene encoding …

We aimed to assess the overall clinical impact of cardiac myosin inhibitors in hypertrophic
cardiomyopathy (HCM). We performed a meta-analysis of published trials assessing the …

Hypertrophic cardiomyopathy (HCM) remains the most common cardiomyopathy in humans
and cats with few preclinical pharmacologic interventional studies. Small-molecule …

Background Hypertrophic cardiomyopathy (HCM) is a genetic disorder with a very large
global burden for which more therapeutic management regimens are required. Objectives In …

Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease,
affecting 1 in 500 individuals in the general population. In 60% of cases, HCM presents an …

Introduction A major focus of interstitial lung disease (ILD) has centered on disorders termed
idiopathic interstitial pneumonias (IIPs) which include, among others, idiopathic pulmonary …

Background Alcohol septal ablation (ASA) is recommended for moderate to severe
symptomatic patients with hypertrophic obstructive cardiomyopathy. The current guidelines …

Hypertrophic cardiomyopathy (HCM) is a genetic myocardial disease of the sarcomere
protein. The age of diagnosis of HCM tends to be between the second to third decades of …